Does the media refer more to DLB or NTNX?

In the previous week, Nutanix had 14 more articles in the media than Dolby Laboratories. MarketBeat recorded 18 mentions for Nutanix and 4 mentions for Dolby Laboratories. Nutanix's average media sentiment score of 0.56 beat Dolby Laboratories' score of -0.07 indicating that Nutanix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dolby Laboratories 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nutanix 7 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor DLB or GEN?

In the previous week, Gen Digital had 7 more articles in the media than Dolby Laboratories. MarketBeat recorded 11 mentions for Gen Digital and 4 mentions for Dolby Laboratories. Gen Digital's average media sentiment score of 0.49 beat Dolby Laboratories' score of -0.07 indicating that Gen Digital is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dolby Laboratories 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Gen Digital 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate NLOK or DLB?

Dolby Laboratories has a consensus price target of $87.50, indicating a potential upside of 50.49%. Given Dolby Laboratories' stronger consensus rating and higher probable upside, analysts clearly believe Dolby Laboratories is more favorable than NortonLifeLock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NortonLifeLock 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Dolby Laboratories 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67

Does the media refer more to NLOK or DLB?

In the previous week, Dolby Laboratories had 3 more articles in the media than NortonLifeLock. MarketBeat recorded 4 mentions for Dolby Laboratories and 1 mentions for NortonLifeLock. NortonLifeLock's average media sentiment score of 0.00 beat Dolby Laboratories' score of -0.07 indicating that NortonLifeLock is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NortonLifeLock 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Dolby Laboratories 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger earnings and valuation, DLB or FROG?

Dolby Laboratories has higher revenue and earnings than JFrog. JFrog is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Dolby Laboratories $1.35B 4.04 $255.02M $2.35 24.74 JFrog $531.84M 22.96 -$71.82M -$0.37 N/A

Does the media refer more to DLB or FROG?

In the previous week, JFrog had 13 more articles in the media than Dolby Laboratories. MarketBeat recorded 17 mentions for JFrog and 4 mentions for Dolby Laboratories. JFrog's average media sentiment score of 0.50 beat Dolby Laboratories' score of -0.07 indicating that JFrog is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dolby Laboratories 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral JFrog 6 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Dolby Laboratories (DLB) Competitors

$58.14 -0.60 (-1.01%)

Closing price 10/12/2026 03:59 PM Eastern

Extended Trading

$58.74 +0.60 (+1.03%)

As of 04:09 AM Eastern

Compare

DLB vs. NTNX, CHKP, GEN, NLOK, and FROG

Should you buy Dolby Laboratories stock or one of its competitors? Dolby Laboratories's main competitors and comparable companies include Nutanix (NTNX), Check Point Software Technologies (CHKP), Gen Digital (GEN), NortonLifeLock (NLOK), and JFrog (FROG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "systems software" industry.

How does Dolby Laboratories compare to Nutanix?

Dolby Laboratories (NYSE:DLB) and Nutanix (NASDAQ:NTNX) are both technology companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings, analyst recommendations and media sentiment.

Dolby Laboratories currently has a consensus target price of $87.50, indicating a potential upside of 50.49%. Nutanix has a consensus target price of $73.07, indicating a potential downside of 1.44%. Given Dolby Laboratories' stronger consensus rating and higher probable upside, research analysts clearly believe Dolby Laboratories is more favorable than Nutanix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dolby Laboratories	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Nutanix	0 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.50

Nutanix has higher revenue and earnings than Dolby Laboratories. Nutanix is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dolby Laboratories	$1.35B	4.04	$255.02M	$2.35	24.74
Nutanix	$2.85B	7.03	$1.51B	$5.16	14.37

Dolby Laboratories has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market. Comparatively, Nutanix has a beta of 0.64, meaning that its stock price is 36% less volatile than the broader market.

58.6% of Dolby Laboratories shares are owned by institutional investors. Comparatively, 85.3% of Nutanix shares are owned by institutional investors. 37.9% of Dolby Laboratories shares are owned by insiders. Comparatively, 2.4% of Nutanix shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Nutanix had 14 more articles in the media than Dolby Laboratories. MarketBeat recorded 18 mentions for Nutanix and 4 mentions for Dolby Laboratories. Nutanix's average media sentiment score of 0.56 beat Dolby Laboratories' score of -0.07 indicating that Nutanix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dolby Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nutanix	7 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Nutanix has a net margin of 52.81% compared to Dolby Laboratories' net margin of 16.70%. Dolby Laboratories' return on equity of 11.08% beat Nutanix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dolby Laboratories	16.70%	11.08%	9.04%
Nutanix	52.81%	-90.13%	9.09%

Summary

Nutanix beats Dolby Laboratories on 10 of the 16 factors compared between the two stocks.

How does Dolby Laboratories compare to Check Point Software Technologies?

Dolby Laboratories (NYSE:DLB) and Check Point Software Technologies (NASDAQ:CHKP) are both technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, risk and dividends.

Dolby Laboratories has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market. Comparatively, Check Point Software Technologies has a beta of 0.48, indicating that its stock price is 52% less volatile than the broader market.

58.6% of Dolby Laboratories shares are owned by institutional investors. Comparatively, 98.5% of Check Point Software Technologies shares are owned by institutional investors. 37.9% of Dolby Laboratories shares are owned by company insiders. Comparatively, 29.0% of Check Point Software Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Check Point Software Technologies has higher revenue and earnings than Dolby Laboratories. Check Point Software Technologies is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dolby Laboratories	$1.35B	4.04	$255.02M	$2.35	24.74
Check Point Software Technologies	$2.73B	5.03	$1.06B	$9.77	13.75

In the previous week, Dolby Laboratories had 1 more articles in the media than Check Point Software Technologies. MarketBeat recorded 4 mentions for Dolby Laboratories and 3 mentions for Check Point Software Technologies. Check Point Software Technologies' average media sentiment score of 0.60 beat Dolby Laboratories' score of -0.07 indicating that Check Point Software Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dolby Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Check Point Software Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Dolby Laboratories presently has a consensus target price of $87.50, suggesting a potential upside of 50.49%. Check Point Software Technologies has a consensus target price of $148.74, suggesting a potential upside of 10.74%. Given Dolby Laboratories' stronger consensus rating and higher possible upside, analysts plainly believe Dolby Laboratories is more favorable than Check Point Software Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dolby Laboratories	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Check Point Software Technologies	0 Sell rating(s)	19 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.30

Check Point Software Technologies has a net margin of 37.93% compared to Dolby Laboratories' net margin of 16.70%. Check Point Software Technologies' return on equity of 38.80% beat Dolby Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dolby Laboratories	16.70%	11.08%	9.04%
Check Point Software Technologies	37.93%	38.80%	15.60%

Summary

Check Point Software Technologies beats Dolby Laboratories on 10 of the 16 factors compared between the two stocks.

How does Dolby Laboratories compare to Gen Digital?

Dolby Laboratories (NYSE:DLB) and Gen Digital (NASDAQ:GEN) are both technology companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings.

Dolby Laboratories pays an annual dividend of $1.44 per share and has a dividend yield of 2.5%. Gen Digital pays an annual dividend of $0.50 per share and has a dividend yield of 2.1%. Dolby Laboratories pays out 61.3% of its earnings in the form of a dividend. Gen Digital pays out 29.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Dolby Laboratories has raised its dividend for 10 consecutive years. Dolby Laboratories is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Dolby Laboratories has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market. Comparatively, Gen Digital has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market.

Gen Digital has higher revenue and earnings than Dolby Laboratories. Gen Digital is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dolby Laboratories	$1.35B	4.04	$255.02M	$2.35	24.74
Gen Digital	$5.08B	2.75	$973M	$1.72	13.58

In the previous week, Gen Digital had 7 more articles in the media than Dolby Laboratories. MarketBeat recorded 11 mentions for Gen Digital and 4 mentions for Dolby Laboratories. Gen Digital's average media sentiment score of 0.49 beat Dolby Laboratories' score of -0.07 indicating that Gen Digital is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dolby Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Gen Digital	1 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Dolby Laboratories presently has a consensus target price of $87.50, suggesting a potential upside of 50.49%. Gen Digital has a consensus target price of $30.25, suggesting a potential upside of 29.55%. Given Dolby Laboratories' stronger consensus rating and higher probable upside, equities analysts plainly believe Dolby Laboratories is more favorable than Gen Digital.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dolby Laboratories	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Gen Digital	0 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.38

Gen Digital has a net margin of 20.73% compared to Dolby Laboratories' net margin of 16.70%. Gen Digital's return on equity of 55.93% beat Dolby Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dolby Laboratories	16.70%	11.08%	9.04%
Gen Digital	20.73%	55.93%	8.91%

58.6% of Dolby Laboratories shares are held by institutional investors. Comparatively, 81.4% of Gen Digital shares are held by institutional investors. 37.9% of Dolby Laboratories shares are held by company insiders. Comparatively, 9.7% of Gen Digital shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Dolby Laboratories and Gen Digital tied by winning 10 of the 20 factors compared between the two stocks.

How does Dolby Laboratories compare to NortonLifeLock?

NortonLifeLock (NASDAQ:NLOK) and Dolby Laboratories (NYSE:DLB) are both technology companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation.

Dolby Laboratories has a consensus price target of $87.50, indicating a potential upside of 50.49%. Given Dolby Laboratories' stronger consensus rating and higher probable upside, analysts clearly believe Dolby Laboratories is more favorable than NortonLifeLock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NortonLifeLock	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Dolby Laboratories	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

94.9% of NortonLifeLock shares are held by institutional investors. Comparatively, 58.6% of Dolby Laboratories shares are held by institutional investors. 3.3% of NortonLifeLock shares are held by insiders. Comparatively, 37.9% of Dolby Laboratories shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Dolby Laboratories has a net margin of 16.70% compared to NortonLifeLock's net margin of 0.00%. Dolby Laboratories' return on equity of 11.08% beat NortonLifeLock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NortonLifeLock	N/A	N/A	N/A
Dolby Laboratories	16.70%	11.08%	9.04%

NortonLifeLock has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market. Comparatively, Dolby Laboratories has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market.

NortonLifeLock pays an annual dividend of $0.50 per share and has a dividend yield of 2.2%. Dolby Laboratories pays an annual dividend of $1.44 per share and has a dividend yield of 2.5%. NortonLifeLock pays out 35.0% of its earnings in the form of a dividend. Dolby Laboratories pays out 61.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Dolby Laboratories has increased its dividend for 10 consecutive years. Dolby Laboratories is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

NortonLifeLock has higher revenue and earnings than Dolby Laboratories. NortonLifeLock is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NortonLifeLock	$2.82B	4.72	$817.05M	$1.43	16.26
Dolby Laboratories	$1.35B	4.04	$255.02M	$2.35	24.74

In the previous week, Dolby Laboratories had 3 more articles in the media than NortonLifeLock. MarketBeat recorded 4 mentions for Dolby Laboratories and 1 mentions for NortonLifeLock. NortonLifeLock's average media sentiment score of 0.00 beat Dolby Laboratories' score of -0.07 indicating that NortonLifeLock is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NortonLifeLock	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Dolby Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Dolby Laboratories beats NortonLifeLock on 13 of the 19 factors compared between the two stocks.

How does Dolby Laboratories compare to JFrog?

Dolby Laboratories (NYSE:DLB) and JFrog (NASDAQ:FROG) are both technology companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership and dividends.

Dolby Laboratories has higher revenue and earnings than JFrog. JFrog is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dolby Laboratories	$1.35B	4.04	$255.02M	$2.35	24.74
JFrog	$531.84M	22.96	-$71.82M	-$0.37	N/A

Dolby Laboratories has a net margin of 16.70% compared to JFrog's net margin of -7.35%. Dolby Laboratories' return on equity of 11.08% beat JFrog's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dolby Laboratories	16.70%	11.08%	9.04%
JFrog	-7.35%	-2.71%	-1.80%

58.6% of Dolby Laboratories shares are owned by institutional investors. Comparatively, 85.0% of JFrog shares are owned by institutional investors. 37.9% of Dolby Laboratories shares are owned by company insiders. Comparatively, 11.8% of JFrog shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Dolby Laboratories has a beta of 0.78, meaning that its share price is 22% less volatile than the broader market. Comparatively, JFrog has a beta of 1.24, meaning that its share price is 24% more volatile than the broader market.

In the previous week, JFrog had 13 more articles in the media than Dolby Laboratories. MarketBeat recorded 17 mentions for JFrog and 4 mentions for Dolby Laboratories. JFrog's average media sentiment score of 0.50 beat Dolby Laboratories' score of -0.07 indicating that JFrog is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dolby Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
JFrog	6 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Dolby Laboratories currently has a consensus price target of $87.50, suggesting a potential upside of 50.49%. JFrog has a consensus price target of $109.48, suggesting a potential upside of 10.56%. Given Dolby Laboratories' higher possible upside, equities analysts clearly believe Dolby Laboratories is more favorable than JFrog.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dolby Laboratories	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
JFrog	1 Sell rating(s)	1 Hold rating(s)	21 Buy rating(s)	0 Strong Buy rating(s)	2.87

Summary

Dolby Laboratories beats JFrog on 9 of the 16 factors compared between the two stocks.

Get Dolby Laboratories News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DLB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DLB vs. The Competition

Export

Metric	Dolby Laboratories	Software Industry	Technology Sector	NYSE Exchange
Market Cap	$5.50B	$16.82B	$31.57B	$23.07B
Dividend Yield	2.46%	3.43%	2.76%	3.72%
P/E Ratio	24.74	144.27	79.76	28.54
Price / Sales	4.02	1,266.65	580.65	14.53
Price / Cash	13.76	44.70	48.28	19.30
Price / Book	2.11	8.97	8.03	4.71
Net Income	$255.02M	$430.53M	$766.25M	$1.07B
7 Day Performance	-0.63%	-0.75%	-2.24%	-0.56%
1 Month Performance	-9.88%	-0.03%	-1.18%	-3.59%
1 Year Performance	-15.49%	0.95%	167.08%	7.41%

Dolby Laboratories Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DLB Dolby Laboratories	4.057 of 5 stars	$58.14 -1.0%	$87.50 +50.5%	-14.7%	$5.50B	$1.35B	24.74	2,051
NTNX Nutanix	2.3055 of 5 stars	$73.41 +1.5%	$73.07 -0.5%	+8.5%	$19.56B	$2.85B	14.23	8,350
CHKP Check Point Software Technologies	3.5156 of 5 stars	$129.58 -0.6%	$148.74 +14.8%	-31.3%	$13.23B	$2.76B	13.26	6,825
GEN Gen Digital	4.971 of 5 stars	$22.28 +1.3%	$30.75 +38.0%	-12.0%	$13.16B	$5B	12.95	3,900	Analyst Forecast
NLOK NortonLifeLock	N/A	$21.99 -1.2%	N/A	-12.3%	$12.56B	$2.82B	15.38	N/A	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:DLB) was last updated on 10/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Dolby Laboratories (DLB) Competitors

DLB vs. NTNX, CHKP, GEN, NLOK, and FROG

How does Dolby Laboratories compare to Nutanix?

Summary

How does Dolby Laboratories compare to Check Point Software Technologies?

Summary

How does Dolby Laboratories compare to Gen Digital?

Summary

How does Dolby Laboratories compare to NortonLifeLock?

Summary

How does Dolby Laboratories compare to JFrog?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DLB vs. The Competition

Dolby Laboratories Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Dolby Laboratories (DLB) Competitors

DLB vs. NTNX, CHKP, GEN, NLOK, and FROG

How does Dolby Laboratories compare to Nutanix?

Do analysts recommend DLB or NTNX?

Which has stronger earnings and valuation, DLB or NTNX?

Which has more risk & volatility, DLB or NTNX?

Do insiders and institutionals believe in DLB or NTNX?

Does the media refer more to DLB or NTNX?

Is DLB or NTNX more profitable?

Summary

How does Dolby Laboratories compare to Check Point Software Technologies?

Which has more volatility & risk, DLB or CHKP?

Do insiders and institutionals have more ownership in DLB or CHKP?

Which has higher earnings & valuation, DLB or CHKP?

Does the media refer more to DLB or CHKP?

Do analysts rate DLB or CHKP?

Is DLB or CHKP more profitable?

Summary

How does Dolby Laboratories compare to Gen Digital?

Is DLB or GEN a better dividend stock?

Which has more risk & volatility, DLB or GEN?

Which has stronger valuation and earnings, DLB or GEN?

Does the media favor DLB or GEN?

Do analysts rate DLB or GEN?

Is DLB or GEN more profitable?

Do insiders & institutionals have more ownership in DLB or GEN?

Summary

How does Dolby Laboratories compare to NortonLifeLock?

Do analysts rate NLOK or DLB?

Do institutionals and insiders hold more shares of NLOK or DLB?

Is NLOK or DLB more profitable?

Which has more risk & volatility, NLOK or DLB?

Is NLOK or DLB a better dividend stock?

Which has higher valuation and earnings, NLOK or DLB?

Does the media refer more to NLOK or DLB?

Summary

How does Dolby Laboratories compare to JFrog?

Which has stronger earnings and valuation, DLB or FROG?

Is DLB or FROG more profitable?

Do institutionals and insiders hold more shares of DLB or FROG?

Which has more risk and volatility, DLB or FROG?

Does the media refer more to DLB or FROG?

Do analysts prefer DLB or FROG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DLB vs. The Competition

Dolby Laboratories Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools